- Investing Ideas
- /
- Bulgarian Pharmaceuticals & Biotech Potentially Undervalued Companies
Bulgarian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
16
5 new
Companies with a Value score of at least 3, ordered by Value score
16 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
TEV | €18.10 | 0% | n/a | €19.3b | €23.77 | PS1.2x | E65.8% | 0% | ||
21P | €6.27 | 0% | n/a | €325.8m | €9.71 | PS1.1x | E154.3% | n/a | ||
BAYN | €19.33 | -6.3% | -40.9% | €19.2b | €27.85 | PS0.4x | E55.7% | 0.6% | ||
SNW New | €90.56 | -3.7% | 8.4% | €113.8b | €113.79 | PE25.3x | E17.9% | 4.1% | ||
MRK New | €138.25 | -19.4% | n/a | €60.7b | €182.96 | PE22.5x | E10.7% | 1.6% | ||
NVV1 | €6.70 | -21.8% | 22.0% | €1.3b | €13.30 | PS1.5x | E67.0% | n/a | ||
EVT | €8.82 | 0% | n/a | €1.8b | €9.82 | PS2.3x | E74.3% | n/a | ||
AYJ | €2.08 | -9.8% | -61.5% | €343.9m | €6.70 | PS2.2x | E4.6% | n/a | ||
2HQ | €1.58 | 0% | n/a | €1.5b | €2.12 | PS1.9x | E84.1% | n/a | ||
6MK | €93.10 | 0% | n/a | €246.5b | €125.24 | PE20.3x | E15.6% | 3.2% | ||
LLY New | €702.70 | -7.2% | n/a | €678.4b | €925.40 | PE81.1x | E29.2% | 0.7% | ||
22UA New | €99.60 | -9.5% | n/a | €25.5b | €133.09 | PS7.6x | E12.0% | n/a | ||
NOV | €96.80 | -3.8% | 4.5% | €3.3t | €125.80 | PE33.9x | E14.4% | 1.4% | ||
PFE | €23.38 | -7.4% | -14.5% | €141.3b | €30.51 | PE33.1x | E16.8% | 6.7% | ||
ZEG New | €119.15 | n/a | n/a | €154.5b | €168.19 | PE30.1x | E18.0% | 2.3% | ||
4AB | €164.86 | 0% | n/a | €296.5b | €201.20 | PE58.3x | E28.1% | 3.9% |
Page 1 of 1